{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:49:43Z","timestamp":1754153383668,"version":"3.41.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Charles B. Hammond Research Fund"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1136\/ijgc-2023-005104","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T13:06:02Z","timestamp":1707483962000},"page":"528-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort study"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5726-5144","authenticated-orcid":false,"given":"Nguyen Thao Thi","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadley","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Previs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J","family":"Havrilesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeles Alvarez","family":"Secord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-005104_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01440","article-title":"Global, regional, and national burden of endometrial cancer, 1990\u20132017: Results From the Global Burden of Disease Study, 2017","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0015","first-page":"258","article-title":"Current recommendations and recent progress in endometrial cancer","volume":"69","author":"Brooks","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2023-005104_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/13697137.2014.944152","article-title":"Endometrial pathology in postmenopausal women with no bleeding","volume":"18","author":"Genc","year":"2015","journal-title":"Climacteric"},{"key":"10.1136\/ijgc-2023-005104_bb0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/014436102320261258","article-title":"Endometrial carcinoma presenting as an adnexal mass","volume":"22","author":"Amagada","year":"2002","journal-title":"J Obstet Gynaecol"},{"key":"10.1136\/ijgc-2023-005104_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2016.09.002","article-title":"Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States","volume":"143","author":"Melamed","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2020.05.063","article-title":"Trends in median survival and upfront treatment among women with advanced ovarian cancer in the United States: 2004-2016","volume":"159","author":"Knisely","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0040","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-005104_bb0045","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Gonz\u00e1lez-Mart\u00edn","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-005104_bb0050","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-005104_bb0055","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N Engl J Med"},{"journal-title":"Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. version 5.2022: accessed","year":"2022","author":"Network NCC","key":"10.1136\/ijgc-2023-005104_bb0060"},{"key":"10.1136\/ijgc-2023-005104_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1136\/ijgc-2023-005104_bb0070","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1136\/ijgc-2023-005104_bb0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ygyno.2021.06.016","article-title":"Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer","volume":"162","author":"Wright","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2021.04.254","article-title":"Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis","volume":"225","author":"Albright","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-005104_bb0085","article-title":"Neoadjuvant chemotherapy for advanced stage endometrial cancer: a systematic review","volume":"38","author":"Huang","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2023-005104_bb0090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0300891618784785","article-title":"Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB serous endometrial cancer","volume":"105","author":"Bogani","year":"2019","journal-title":"Tumori"},{"key":"10.1136\/ijgc-2023-005104_bb0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ygyno.2013.08.036","article-title":"Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan","volume":"131","author":"Eto","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.04.018","article-title":"Factors prognostic of survival in advanced-stage uterine serous carcinoma","volume":"146","author":"Holman","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejogrb.2018.11.029","article-title":"Advanced stage (IIIC\/IV) endometrial cancer: role of cytoreduction and determinants of survival","volume":"234","author":"Rajkumar","year":"2019","journal-title":"Eur J Obst Gynecol Reproduct Biol"},{"key":"10.1136\/ijgc-2023-005104_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IGC.0000000000000321","article-title":"Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma","volume":"25","author":"Wilkinson-Ryan","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005104_bb0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2022.03.021","article-title":"Population-level uptake of neoadjuvant chemotherapy for stage IVB endometrial cancer","volume":"165","author":"Jooya","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"143","author":"Wright","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0125","article-title":"Evaluation of the incidence and clinical significance of WT-1 expression in uterine serous carcinoma","volume":"39","author":"McEachron","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2023-005104_bb0130","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/1055-9965.EPI-15-0316","article-title":"The growing burden of endometrial cancer: a major racial disparity affecting black women","volume":"24","author":"Cote","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2023-005104_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/gyno.1996.4594","article-title":"Impact of ethnicity on the incidence of high-risk endometrial carcinoma","volume":"65","author":"Plaxe","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005104_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081900","article-title":"Histopathologic, genetic and molecular characterization of endometrial cancer racial disparity","volume":"13","author":"Javadian","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-005104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:20:28Z","timestamp":1753230028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24013598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1048891X24013598"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-005104","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-005104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}